Literature DB >> 18021306

Double-blindness protects scientific validity.

C D Furberg1, E Z Soliman.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18021306     DOI： 10.1111/j.1538-7836.2007.02836.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb).

Authors:  Shintaro Maki; Hiroaki Tanaka; Sho Takakura; Masafumi Nii; Kayo Tanaka; Toru Ogura; Mayumi Kotera; Yuki Nishimura; Satoshi Tamaru; Takafumi Ushida; Yasuhiro Tanaka; Norihiko Kikuchi; Tadatsugu Kinjo; Hiroshi Kawamura; Mayumi Takano; Koji Nakamura; Sachie Suga; Michi Kasai; Osamu Yasui; Kenji Nagao; Yuka Maegawa; Tomomi Kotani; Masayuki Endo; Ichiro Yasuhi; Shigeru Aoki; Yoichi Aoki; Yoshio Yoshida; Masahiko Nakata; Akihiko Sekizawa; Tomoaki Ikeda
Journal:  BMJ Open       Date:  2022-06-14       Impact factor: 3.006

2.  The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.

Authors:  Pei-Yin Pan; Meei-Shyuan Lee; Chin-Bin Yeh
Journal:  BMC Psychiatry       Date:  2015-01-22       Impact factor: 3.630

3.  Attitudes towards open-label versus placebo-control designs in oncology randomized trials: A survey of medical oncologists.

Authors:  Igal Kushnir; Mark Clemons; Dean Fergusson; Dominick Bossé; Martin Neil Reaume
Journal:  J Eval Clin Pract       Date:  2022-02-21       Impact factor: 2.336

4.  Random Guess and Wishful Thinking are the Best Blinding Scenarios.

Authors:  Heejung Bang
Journal:  Contemp Clin Trials Commun       Date:  2016-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.